Skip to content

Recovery Management Intervention in China

Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01270100
Enrollment
Unknown
Registered
2011-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2011-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Methadone

Brief summary

The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China. The project has the following specific aims: Primary aims: Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care. Secondary aim: Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors. It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors

Interventions

BEHAVIORALRecovery management

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of California, Los Angeles
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

The study population will be drawn from all adult patients at participating compulsory rehabilitation facilities who: 1. have been incarcerated for at least one year and would have been eligible for MMT at the time of incarceration, 2. have at least 1 month remaining before release, 3. met the DSM-IV criteria for heroin dependence at the time of incarceration, 4. are willing to enroll in methadone maintenance treatment, and 5. are Shanghai residents who reside in the areas of Shanghai targeted by the study.

Exclusion criteria

Individuals diagnosed with severe mental illness will not be eligible to participate.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026